Session 60: Meningiomas: Current Treatment Paradigms and Future Improvements
Tracks
Hall 2
| Friday, October 2, 2026 |
| 3:00 PM - 4:30 PM |
Details
Matthias Simon, Michael Jenkinson
Speakers & Chairs
Erkin Ozgiray
Microneurosurgical approach to falx meningiomas
3:00 PM - 3:10 PM
Dr Nico Teske
Resident Neurosurgeon
Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
SSRI-PET in meningioma - current and future role
3:10 PM - 3:20 PM
Christian Mirian Larsen
When to irradiate for meningioma?
3:20 PM - 3:30 PM
Mr Didar Fares
Medical Student
Rigshospitalet
Ki-67 Expression in Neoplastic and Inflammatory Cells of Meningiomas
Mr Klejdi Nurellari
Medical Student, Doctoral Candidate
University Clinic Freiburg
Immune Microenvironment Profiling Reveals Grade-Independent Subgroups and a Selective T Cell Recruitment Deficit in Meningioma
Dr Jakob Rossmann
Resident
Klinikum Nürnberg Süd
Growth of a meningioma cell line on cranioplastic material in cell culture
Dr. Charles Champeaux Depond
Consultant Neurosurgeon
Hôpital Privé Clairval
Survival after meningioma surgery. A 17-year nationwide study.
Dr. Massimiliano Del Bene
Dr
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
Tumor Lymphocytic Infiltration and Recurrence Risk in Atypical Meningiomas
Dr Jeppe Haslund-Vinding
Resident, Phd Fellow
Rigshospitalet
Extent of resection of meningioma: First experience after implementation of the Copenhagen Protocol for grading of meningioma resection
Dr Yoichi Uozumi
Assistant Professor
Department of Neurosurgery, Kobe University Graduate School of Medicine
Risk factors for postoperative decline of factor XIII activity in patients with normal preoperative FXIII undergoing craniotomy for brain tumors
Discussion
Discussion
4:25 PM - 4:30 PM
Prof. Michael Jenkinson
Professor Of Surgical Trials And Neurosurgery
University Of Liverpool
Chair
Matthias Simon
Chair
